General Information of the Compound
| Compound ID |
CP0281148
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
TANAPROGET
Show/Hide
|
||||||||||||||||||
| Synonyms |
1zuc
304853-42-7
5-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbonitrile
AC1NA08O
AKOS030526776
BDBM50375821
CHEMBL539163
CS-1550
D06003
DB04787
DTXSID00184556
FT-0735521
GTPL7416
HY-15606
KB-145966
NSP 989
NSP-989
NSP-989;NSP 989;NSP989
PYVFWTPEBMRKSR-UHFFFAOYSA-N
SB17247
SCHEMBL62188
T98
Tanaproget
Tanaproget (USAN/INN)
Tanaproget [USAN:INN]
UNII-W9F9H8GXWR
W-5758
W9F9H8GXWR
ZINC6245719
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H15N3OS
|
||||||||||||||||||
| Molecular Weight |
297.383
|
||||||||||||||||||
| Canonical SMILES |
Cn1c(ccc1-c1ccc2NC(=S)OC(C)(C)c2c1)C#N
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H15N3OS/c1-16(2)12-8-10(4-6-13(12)18-15(21)20-16)14-7-5-11(9-17)19(14)3/h4-8H,1-3H3,(H,18,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PYVFWTPEBMRKSR-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
304853-42-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound